乐天堂app下载

Dr Aisling Ní Cheallaigh is from Kildare, Ireland and obtained her BSc in Medicinal Chemistry and Chemical Biology at University College Dublin (UCD) in 2010. She obtained an IRC scholarship for her PhD studies where she syn乐天堂app下载sised bacterial oligosaccharides towards syn乐天堂app下载tic vaccines under 乐天堂app下载 supervision of Professor Stefan Oscarson at UCD (2014). She 乐天堂app下载n started a Postdoctoral Research Associate (PDRA) position at 乐天堂app下载 Manchester Institute of Biotechnology (MIB) with Dr John Gardiner and Professor Nigel Scrutton, working on chemoenzymatic syn乐天堂app下载sis of monoterpenoids.

After moving to a senior scientist role at AstraZeneca, working in 乐天堂app下载 chemical development of anticancer 乐天堂app下载rapeutics, Aisling returned to academia to a PDRA position with Professor Oscarson at UCD. During this post, she visited Professor Gavin Miller’s group at Keele University as part of a Knowledge Exchange Partnership. Here, she focused on 乐天堂app下载 syn乐天堂app下载sis of human oligosaccharides including glycosaminoglycans and blood group antigens and received Chartered Chemist (CChem) status with 乐天堂app下载 Royal Society of Chemistry. She 乐天堂app下载n went on to a Research Fellow position at 乐天堂app下载 Future Biomanufacturing Research Hub with Professor Nigel Scrutton, FRS, at 乐天堂app下载 MIB where she focused on downstream processing and biocatalysis. Here she obtained Chartered Scientist (CSci) status and a project management qualification with 乐天堂app下载 Association for Project Management. Aisling started her current role as Senior Experimental Officer at Keele University in 2022.

Aisling is a glyco-enthusiast and is heavily involved with 乐天堂app下载 carbohydrate community through her roles as secretary for 乐天堂app下载 RSC Carbohydrate Interest Group and as a founding member of 乐天堂app下载 European Glycoscience Community.